Work

Incidence of invasive breast cancer following 8 years of raloxifene therapy in postmenopausal women with osteoporosis: Results from the Continuing Outcomes Relevant to Evista (CORE) trial

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.1000

Authors: S. Martino, J. A. Cauley, E. Barrett-Connor, T. J. Powles, J. L. Mershon, D. Disch, R. J. Secrest, S. R. Cummings

Institutions: Eli Lilly (United States), University of Pittsburgh, California Pacific Medical Center, University of California San Diego

Language: English

Topic: Menopause: Health Impacts and Treatments

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2267460932

Cites:

Cited by: 10

Related to: 10